Around the same time, Hubin and coworkers hypothesized that the simultaneous inhibition of CCR5 and CXCR4 by transition metal complexes based on a tetraazamacrocycle could be particularly effective for the treatment of HIV infection (Figure 4) [27,28]. Here, CXCR4 is linked to HIV infectious disease.